UniProt ID | AAPK1_HUMAN | |
---|---|---|
UniProt AC | Q13131 | |
Protein Name | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | |
Gene Name | PRKAA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 559 | |
Subcellular Localization | Cytoplasm . Nucleus . In response to stress, recruited by p53/TP53 to specific promoters. | |
Protein Description | Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. In response to nutrient limitation, phosphorylates transcription factor FOXO3 promoting FOXO3 mitochontrial import (By similarity). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.. | |
Protein Sequence | MRRLSSWRKMATAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDEITEAKSGTATPQRSGSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPGSHTIEFFEMCANLIKILAQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MRRLSSWRKMAT ---CCCHHHHHHHHH | 26.50 | 28674151 | |
6 | Phosphorylation | --MRRLSSWRKMATA --CCCHHHHHHHHHH | 35.18 | 46163063 | |
22 | Ubiquitination | KQKHDGRVKIGHYIL HHCCCCCEEEEEEEC | 6.92 | 22817900 | |
27 | Ubiquitination | GRVKIGHYILGDTLG CCEEEEEEECCCCEE | 7.82 | 22817900 | |
32 | Phosphorylation | GHYILGDTLGVGTFG EEEECCCCEECCCCC | 24.50 | 28857561 | |
37 | Phosphorylation | GDTLGVGTFGKVKVG CCCEECCCCCEEEEC | 27.15 | 28857561 | |
40 | Acetylation | LGVGTFGKVKVGKHE EECCCCCEEEECCEE | 34.39 | 25953088 | |
40 | Ubiquitination | LGVGTFGKVKVGKHE EECCCCCEEEECCEE | 34.39 | 19608861 | |
40 (in isoform 2) | Ubiquitination | - | 34.39 | - | |
45 | Ubiquitination | FGKVKVGKHELTGHK CCEEEECCEECCCCE | 36.57 | 29967540 | |
52 | Acetylation | KHELTGHKVAVKILN CEECCCCEEHHHHHC | 32.98 | 25953088 | |
52 | Ubiquitination | KHELTGHKVAVKILN CEECCCCEEHHHHHC | 32.98 | 29967540 | |
54 | Ubiquitination | ELTGHKVAVKILNRQ ECCCCEEHHHHHCHH | 11.16 | 24816145 | |
56 | Ubiquitination | TGHKVAVKILNRQKI CCCEEHHHHHCHHHC | 31.57 | 29967540 | |
56 (in isoform 2) | Ubiquitination | - | 31.57 | - | |
65 | Phosphorylation | LNRQKIRSLDVVGKI HCHHHCCCCHHHHHH | 32.18 | 28857561 | |
71 | Acetylation | RSLDVVGKIRREIQN CCCHHHHHHHHHHHC | 22.79 | 25953088 | |
71 | Ubiquitination | RSLDVVGKIRREIQN CCCHHHHHHHHHHHC | 22.79 | 33845483 | |
80 | Acetylation | RREIQNLKLFRHPHI HHHHHCCCCCCCHHH | 53.80 | 22637185 | |
80 | Ubiquitination | RREIQNLKLFRHPHI HHHHHCCCCCCCHHH | 53.80 | 24816145 | |
80 (in isoform 2) | Malonylation | - | 53.80 | 26320211 | |
130 | Ubiquitination | DEKESRRLFQQILSG CHHHHHHHHHHHHHC | 4.40 | 29967540 | |
138 | Ubiquitination | FQQILSGVDYCHRHM HHHHHHCCHHHHHHC | 4.21 | 21963094 | |
139 | Ubiquitination | QQILSGVDYCHRHMV HHHHHCCHHHHHHCE | 43.82 | 21963094 | |
140 | Ubiquitination | QILSGVDYCHRHMVV HHHHCCHHHHHHCEE | 6.43 | 22817900 | |
152 | Ubiquitination | MVVHRDLKPENVLLD CEECCCCCHHHEEEE | 55.35 | - | |
154 | Ubiquitination | VHRDLKPENVLLDAH ECCCCCHHHEEEEHH | 59.38 | 21963094 | |
165 | Ubiquitination | LDAHMNAKIADFGLS EEHHHCHHHHCCCHH | 33.16 | 21963094 | |
167 (in isoform 2) | Ubiquitination | - | 12.84 | - | |
172 | Phosphorylation | KIADFGLSNMMSDGE HHHCCCHHHCCCCCC | 24.06 | 22322096 | |
174 | Phosphorylation | ADFGLSNMMSDGEFL HCCCHHHCCCCCCHH | 2.15 | 8910387 | |
175 | Phosphorylation | DFGLSNMMSDGEFLR CCCHHHCCCCCCHHH | 3.75 | 18669648 | |
176 | Phosphorylation | FGLSNMMSDGEFLRT CCHHHCCCCCCHHHH | 31.53 | 26657352 | |
178 | Phosphorylation | LSNMMSDGEFLRTSC HHHCCCCCCHHHHCC | 21.90 | 18220336 | |
180 | Ubiquitination | NMMSDGEFLRTSCGS HCCCCCCHHHHCCCC | 7.37 | 21963094 | |
183 | Phosphorylation | SDGEFLRTSCGSPNY CCCCHHHHCCCCCCC | 30.43 | 22322096 | |
184 | Phosphorylation | DGEFLRTSCGSPNYA CCCHHHHCCCCCCCC | 15.28 | 22322096 | |
185 | S-nitrosylation | GEFLRTSCGSPNYAA CCHHHHCCCCCCCCC | 6.55 | 2212679 | |
187 | Phosphorylation | FLRTSCGSPNYAAPE HHHHCCCCCCCCCCH | 17.82 | 22322096 | |
190 | Phosphorylation | TSCGSPNYAAPEVIS HCCCCCCCCCCHHHC | 13.92 | 26552605 | |
197 | Phosphorylation | YAAPEVISGRLYAGP CCCCHHHCCCCCCCC | 24.04 | 26552605 | |
198 | Phosphorylation | AAPEVISGRLYAGPE CCCHHHCCCCCCCCC | 16.70 | 27251275 | |
199 | Ubiquitination | APEVISGRLYAGPEV CCHHHCCCCCCCCCC | 20.10 | 21963094 | |
227 | Ubiquitination | CGTLPFDDDHVPTLF HCCCCCCCCCHHHHH | 48.58 | 21963094 | |
243 | Phosphorylation | KICDGIFYTPQYLNP HHCCCCCCCHHHCCH | 18.65 | 21406692 | |
244 | Phosphorylation | ICDGIFYTPQYLNPS HCCCCCCCHHHCCHH | 7.99 | 21406692 | |
247 | Phosphorylation | GIFYTPQYLNPSVIS CCCCCHHHCCHHHHH | 15.06 | 21406692 | |
251 | Phosphorylation | TPQYLNPSVISLLKH CHHHCCHHHHHHHHH | 30.89 | 21406692 | |
254 | Phosphorylation | YLNPSVISLLKHMLQ HCCHHHHHHHHHHHC | 26.03 | 24719451 | |
254 | Ubiquitination | YLNPSVISLLKHMLQ HCCHHHHHHHHHHHC | 26.03 | 22817900 | |
259 | Ubiquitination | VISLLKHMLQVDPMK HHHHHHHHHCCCCCC | 2.40 | 22817900 | |
266 | Ubiquitination | MLQVDPMKRATIKDI HHCCCCCCCCCHHHH | 44.24 | 29967540 | |
269 | Phosphorylation | VDPMKRATIKDIREH CCCCCCCCHHHHHHC | 32.37 | - | |
269 | Ubiquitination | VDPMKRATIKDIREH CCCCCCCCHHHHHHC | 32.37 | 22817900 | |
271 | Ubiquitination | PMKRATIKDIREHEW CCCCCCHHHHHHCHH | 42.63 | 29967540 | |
274 | Ubiquitination | RATIKDIREHEWFKQ CCCHHHHHHCHHHHC | 49.72 | 22817900 | |
276 (in isoform 1) | Ubiquitination | - | 27.95 | 21906983 | |
280 | Ubiquitination | IREHEWFKQDLPKYL HHHCHHHHCCCCHHC | 43.93 | 22817900 | |
281 | Ubiquitination | REHEWFKQDLPKYLF HHCHHHHCCCCHHCC | 48.26 | 29967540 | |
281 (in isoform 2) | Ubiquitination | - | 48.26 | - | |
285 | Ubiquitination | WFKQDLPKYLFPEDP HHHCCCCHHCCCCCC | 62.98 | 21906983 | |
286 | Phosphorylation | FKQDLPKYLFPEDPS HHCCCCHHCCCCCCC | 16.19 | 28796482 | |
286 | Ubiquitination | FKQDLPKYLFPEDPS HHCCCCHHCCCCCCC | 16.19 | 29967540 | |
291 (in isoform 2) | Ubiquitination | - | 37.37 | 21906983 | |
293 | Phosphorylation | YLFPEDPSYSSTMID HCCCCCCCCCCCCCC | 50.39 | 28796482 | |
294 | Phosphorylation | LFPEDPSYSSTMIDD CCCCCCCCCCCCCCH | 16.42 | 28796482 | |
295 | Phosphorylation | FPEDPSYSSTMIDDE CCCCCCCCCCCCCHH | 24.54 | 28796482 | |
295 | Ubiquitination | FPEDPSYSSTMIDDE CCCCCCCCCCCCCHH | 24.54 | 22817900 | |
295 (in isoform 2) | Ubiquitination | - | 24.54 | - | |
296 | Phosphorylation | PEDPSYSSTMIDDEA CCCCCCCCCCCCHHH | 17.48 | 28796482 | |
297 | Phosphorylation | EDPSYSSTMIDDEAL CCCCCCCCCCCHHHH | 16.53 | 28796482 | |
300 | Ubiquitination | SYSSTMIDDEALKEV CCCCCCCCHHHHHHH | 36.55 | 22817900 | |
309 | Phosphorylation | EALKEVCEKFECSEE HHHHHHHHHCCCCHH | 66.99 | 27642862 | |
346 | Phosphorylation | IDNRRIMNEAKDFYL HCCHHHHHHHHCEEE | 43.64 | 18669648 | |
347 | Phosphorylation | DNRRIMNEAKDFYLA CCHHHHHHHHCEEEE | 39.45 | 18669648 | |
350 | Phosphorylation | RIMNEAKDFYLATSP HHHHHHHCEEEECCC | 44.46 | 27642862 | |
352 | Phosphorylation | MNEAKDFYLATSPPD HHHHHCEEEECCCCC | 12.93 | 29255136 | |
355 | Phosphorylation | AKDFYLATSPPDSFL HHCEEEECCCCCCCC | 38.89 | 29255136 | |
356 | Phosphorylation | KDFYLATSPPDSFLD HCEEEECCCCCCCCC | 28.91 | 29255136 | |
360 | Phosphorylation | LATSPPDSFLDDHHL EECCCCCCCCCCCCC | 33.22 | 29255136 | |
367 | Phosphorylation | SFLDDHHLTRPHPER CCCCCCCCCCCCCCC | 3.79 | 27642862 | |
368 | Phosphorylation | FLDDHHLTRPHPERV CCCCCCCCCCCCCCC | 37.49 | 23663014 | |
370 | Phosphorylation | DDHHLTRPHPERVPF CCCCCCCCCCCCCCE | 41.99 | 24719451 | |
370 | Ubiquitination | DDHHLTRPHPERVPF CCCCCCCCCCCCCCE | 41.99 | 21963094 | |
372 | Ubiquitination | HHLTRPHPERVPFLV CCCCCCCCCCCCEEE | 33.50 | 22817900 | |
373 | Phosphorylation | HLTRPHPERVPFLVA CCCCCCCCCCCEEEE | 64.38 | 18669648 | |
375 | Phosphorylation | TRPHPERVPFLVAET CCCCCCCCCEEEECC | 3.61 | 27642862 | |
382 | Phosphorylation | VPFLVAETPRARHTL CCEEEECCHHHCCCH | 14.34 | 29255136 | |
385 | Ubiquitination | LVAETPRARHTLDEL EEECCHHHCCCHHHH | 14.60 | 21963094 | |
387 | Ubiquitination | AETPRARHTLDELNP ECCHHHCCCHHHHCC | 29.78 | 22817900 | |
387 (in isoform 1) | Ubiquitination | - | 29.78 | 21906983 | |
388 | Phosphorylation | ETPRARHTLDELNPQ CCHHHCCCHHHHCCC | 30.28 | 23663014 | |
396 | Ubiquitination | LDELNPQKSKHQGVR HHHHCCCCCCCCCCH | 63.83 | 21906983 | |
397 | Phosphorylation | DELNPQKSKHQGVRK HHHCCCCCCCCCCHH | 30.07 | 28857561 | |
398 | Ubiquitination | ELNPQKSKHQGVRKA HHCCCCCCCCCCHHH | 47.16 | 22817900 | |
402 (in isoform 2) | Ubiquitination | - | 4.58 | 21906983 | |
403 | Phosphorylation | KSKHQGVRKAKWHLG CCCCCCCHHHHHCCC | 39.79 | 27251275 | |
406 | Sumoylation | HQGVRKAKWHLGIRS CCCCHHHHHCCCCCC | 37.88 | - | |
406 | Sumoylation | HQGVRKAKWHLGIRS CCCCHHHHHCCCCCC | 37.88 | - | |
406 | Ubiquitination | HQGVRKAKWHLGIRS CCCCHHHHHCCCCCC | 37.88 | - | |
411 | Ubiquitination | KAKWHLGIRSQSRPN HHHHCCCCCCCCCCC | 4.88 | 21963094 | |
411 (in isoform 2) | Ubiquitination | - | 4.88 | - | |
413 | Ubiquitination | KWHLGIRSQSRPNDI HHCCCCCCCCCCCHH | 30.50 | 22817900 | |
421 (in isoform 2) | Malonylation | - | 2.65 | 32601280 | |
421 (in isoform 2) | Ubiquitination | - | 2.65 | - | |
429 | Acetylation | AEVCRAIKQLDYEWK HHHHHHHHHCCCEEE | 43.77 | 25953088 | |
429 | Ubiquitination | AEVCRAIKQLDYEWK HHHHHHHHHCCCEEE | 43.77 | 29967540 | |
431 | Ubiquitination | VCRAIKQLDYEWKVV HHHHHHHCCCEEEEE | 6.86 | 21963094 | |
441 | Phosphorylation | EWKVVNPYYLRVRRK EEEEECCEEEEEEEC | 15.21 | 51241 | |
442 | Phosphorylation | WKVVNPYYLRVRRKN EEEECCEEEEEEECC | 6.84 | 51247 | |
444 | Ubiquitination | VVNPYYLRVRRKNPV EECCEEEEEEECCCC | 12.08 | 29967540 | |
444 (in isoform 2) | Ubiquitination | - | 12.08 | - | |
446 | Ubiquitination | NPYYLRVRRKNPVTS CCEEEEEEECCCCCC | 37.10 | 21963094 | |
448 | Ubiquitination | YYLRVRRKNPVTSTY EEEEEEECCCCCCCC | 55.85 | 29967540 | |
457 | Ubiquitination | PVTSTYSKMSLQLYQ CCCCCCEEEEEEEEE | 23.30 | 21963094 | |
459 | Ubiquitination | TSTYSKMSLQLYQVD CCCCEEEEEEEEEEC | 19.39 | 21963094 | |
463 | Phosphorylation | SKMSLQLYQVDSRTY EEEEEEEEEECCCEE | 8.11 | 8391907 | |
463 | Ubiquitination | SKMSLQLYQVDSRTY EEEEEEEEEECCCEE | 8.11 | 29967540 | |
467 | Phosphorylation | LQLYQVDSRTYLLDF EEEEEECCCEEEEEE | 27.89 | 19060867 | |
472 | Ubiquitination | VDSRTYLLDFRSIDD ECCCEEEEEECCCCH | 4.05 | 21963094 | |
473 | Phosphorylation | DSRTYLLDFRSIDDE CCCEEEEEECCCCHH | 34.03 | 18669648 | |
474 | Ubiquitination | SRTYLLDFRSIDDEI CCEEEEEECCCCHHH | 7.14 | 21963094 | |
476 | Phosphorylation | TYLLDFRSIDDEITE EEEEEECCCCHHHHC | 30.29 | 28176443 | |
476 (in isoform 1) | Ubiquitination | - | 30.29 | 21906983 | |
477 | Phosphorylation | YLLDFRSIDDEITEA EEEEECCCCHHHHCC | 7.25 | 18669648 | |
479 | Phosphorylation | LDFRSIDDEITEAKS EEECCCCHHHHCCCC | 47.75 | 18669648 | |
481 | Phosphorylation | FRSIDDEITEAKSGT ECCCCHHHHCCCCCC | 5.62 | 18669648 | |
482 | Phosphorylation | RSIDDEITEAKSGTA CCCCHHHHCCCCCCC | 28.04 | 28176443 | |
485 | Ubiquitination | DDEITEAKSGTATPQ CHHHHCCCCCCCCCC | 43.09 | 21906983 | |
486 | Phosphorylation | DEITEAKSGTATPQR HHHHCCCCCCCCCCC | 48.72 | 22322096 | |
487 | Phosphorylation | EITEAKSGTATPQRS HHHCCCCCCCCCCCC | 20.75 | 18669648 | |
488 | Phosphorylation | ITEAKSGTATPQRSG HHCCCCCCCCCCCCC | 34.15 | 22322096 | |
490 | Phosphorylation | EAKSGTATPQRSGSV CCCCCCCCCCCCCCC | 21.57 | 22322096 | |
491 (in isoform 2) | Ubiquitination | - | 25.73 | 21906983 | |
494 | Phosphorylation | GTATPQRSGSVSNYR CCCCCCCCCCCCCCC | 30.12 | 25159151 | |
496 | Phosphorylation | ATPQRSGSVSNYRSC CCCCCCCCCCCCCCC | 24.50 | 22322096 | |
498 | Phosphorylation | PQRSGSVSNYRSCQR CCCCCCCCCCCCCCC | 29.82 | 21955146 | |
500 | Phosphorylation | RSGSVSNYRSCQRSD CCCCCCCCCCCCCCC | 9.08 | 27362937 | |
500 | Ubiquitination | RSGSVSNYRSCQRSD CCCCCCCCCCCCCCC | 9.08 | 21963094 | |
500 (in isoform 2) | Ubiquitination | - | 9.08 | - | |
501 | Phosphorylation | SGSVSNYRSCQRSDS CCCCCCCCCCCCCCC | 34.90 | 27251275 | |
502 | Phosphorylation | GSVSNYRSCQRSDSD CCCCCCCCCCCCCCC | 12.30 | 26552605 | |
503 | Phosphorylation | SVSNYRSCQRSDSDA CCCCCCCCCCCCCCH | 2.63 | 27251275 | |
506 | Phosphorylation | NYRSCQRSDSDAEAQ CCCCCCCCCCCHHHC | 18.65 | 8546373 | |
508 | Phosphorylation | RSCQRSDSDAEAQGK CCCCCCCCCHHHCCC | 39.71 | 28102081 | |
511 | Phosphorylation | QRSDSDAEAQGKSSE CCCCCCHHHCCCCCE | 46.66 | 24719451 | |
515 | Ubiquitination | SDAEAQGKSSEVSLT CCHHHCCCCCEEEEE | 38.43 | - | |
516 | Phosphorylation | DAEAQGKSSEVSLTS CHHHCCCCCEEEEEE | 38.26 | 23663014 | |
517 | Phosphorylation | AEAQGKSSEVSLTSS HHHCCCCCEEEEEEC | 45.57 | 23663014 | |
520 | Phosphorylation | QGKSSEVSLTSSVTS CCCCCEEEEEECCEE | 23.13 | 25072903 | |
521 | Phosphorylation | GKSSEVSLTSSVTSL CCCCEEEEEECCEEC | 6.95 | 33259812 | |
522 | Phosphorylation | KSSEVSLTSSVTSLD CCCEEEEEECCEECC | 16.08 | 25072903 | |
523 | Phosphorylation | SSEVSLTSSVTSLDS CCEEEEEECCEECCC | 28.27 | 30631047 | |
524 | Phosphorylation | SEVSLTSSVTSLDSS CEEEEEECCEECCCC | 24.95 | 30631047 | |
526 | Phosphorylation | VSLTSSVTSLDSSPV EEEEECCEECCCCCC | 26.06 | 30631047 | |
527 | Phosphorylation | SLTSSVTSLDSSPVD EEEECCEECCCCCCC | 28.20 | 30631047 | |
530 | Phosphorylation | SSVTSLDSSPVDLTP ECCEECCCCCCCCCC | 41.66 | 25072903 | |
531 | Phosphorylation | SVTSLDSSPVDLTPR CCEECCCCCCCCCCC | 28.71 | 23663014 | |
536 | Phosphorylation | DSSPVDLTPRPGSHT CCCCCCCCCCCCCCH | 16.88 | 26074081 | |
538 | Phosphorylation | SPVDLTPRPGSHTIE CCCCCCCCCCCCHHH | 42.87 | 27251275 | |
541 | Phosphorylation | DLTPRPGSHTIEFFE CCCCCCCCCHHHHHH | 21.82 | 26074081 | |
543 | Phosphorylation | TPRPGSHTIEFFEMC CCCCCCCHHHHHHHH | 24.73 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
174 | T | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
174 | T | Phosphorylation | Kinase | STK11 | Q15831 | PhosphoELM |
183 | T | Phosphorylation | Kinase | CAMK2B | Q13554 | PSP |
183 | T | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
183 | T | Phosphorylation | Kinase | LKB1 | Q9WTK7 | PSP |
183 | T | Phosphorylation | Kinase | STK11 | Q15831 | GPS |
183 | T | Phosphorylation | Kinase | MAP3K11 | Q16584 | GPS |
183 | T | Phosphorylation | Kinase | CAMKK2 | Q96RR4 | Uniprot |
183 | T | Phosphorylation | Kinase | CAMKK1 | Q8N5S9 | PSP |
183 | T | Phosphorylation | Kinase | BRSK1 | Q8TDC3-2 | GPS |
183 | T | Phosphorylation | Kinase | BRSK2 | Q8IWQ3 | PSP |
183 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
360 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
360 | S | Phosphorylation | Kinase | ULK1 | O75385 | Uniprot |
368 | T | Phosphorylation | Kinase | ULK1 | O75385 | Uniprot |
388 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
482 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
486 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
486 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
490 | T | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
490 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
494 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
494 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
496 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
496 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
496 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
496 | S | Phosphorylation | Kinase | PKCA | P04409 | PSP |
496 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM28 | Q13263 | PMID:25945414 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AAPK1_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-32; THR-183; SER-184;SER-187; THR-355; SER-356; SER-397; TYR-441; SER-467; SER-476;SER-486; THR-488; THR-490; SER-496; SER-502; SER-506; SER-508;SER-516; SER-520; THR-522; SER-523; SER-524 AND SER-527, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-382; SER-486;THR-490 AND SER-496, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-486; THR-490;SER-496; SER-508; SER-523 AND SER-527, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382 AND THR-490, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-442, AND MASSSPECTROMETRY. |